Polyamine Depletion Induces G1 and S Phase Arrest in Human Retinoblastoma Y79 Cells

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2008 Jan 23

PMID 18208615

Citations 4

Authors

Akiko Ueda

Makoto Araie

Shunichiro Kubota

Affiliations

Soon will be listed here.

Abstract

Background: Polyamines and ornithine decarboxylase (ODC) are essential for cell proliferation. DL-alpha-difluoromethylornithine (DFMO), a synthetic inhibitor of ODC, induces G1 arrest through dephosphorylation of retinoblastoma protein (pRb). The effect of DFMO on cell growth of pRb deficient cells is not known. We examined the effects of DFMO on pRb deficient human retinoblastoma Y79 cell proliferation and its molecular mechanism.

Methods: Using cultured Y79 cells, the effects of DFMO were studied by using polyamine analysis, western blot, gel shift, FACS and promoter analysis.

Results: DFMO suppressed the proliferation of Y79 cells, which accumulated in the G1 and S phase. DFMO induced p27/Kip1 protein expression, p107 dephosphorylation and accumulation of p107/E2F-4 complex in Y79 cells.

Conclusion: These results indicate that p107 dephosphorylation and accumulation of p107/E2F-4 complex is involved in G1 and S phase arrest of DFMO treated Y79 cells.

Citing Articles

Polyamines and Their Metabolism: From the Maintenance of Physiological Homeostasis to the Mediation of Disease.

Zahedi K, Barone S, Soleimani M Med Sci (Basel). 2022; 10(3).

PMID: 35893120 PMC: 9326668. DOI: 10.3390/medsci10030038.

Involvement of Antizyme Characterized from the Small Abalone Haliotis diversicolor in Gonadal Development.

Li W, Huang M, Lu W, Chen X, Shen M, Li X PLoS One. 2015; 10(8):e0135251.

PMID: 26313647 PMC: 4551804. DOI: 10.1371/journal.pone.0135251.

Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells.

Alexiou G, Tsamis K, Vartholomatos E, Peponi E, Tzima E, Tasiou I J Neurooncol. 2015; 123(2):217-24.

PMID: 25935110 DOI: 10.1007/s11060-015-1799-9.

Cytotoxicity of 1,4-diamino-2-butanone, a putrescine analogue, to RKO cells: mechanism and redox imbalance.

Soares C, Boiani M, Marnett L, Bechara E Free Radic Res. 2013; 47(9):672-82.

PMID: 23758064 PMC: 6525713. DOI: 10.3109/10715762.2013.814126.

References

Russell D . Ornithine decarboxylase as a biological and pharmacological tool. Pharmacology. 1980; 20(3):117-29. DOI: 10.1159/000137355. View

Luo R, Postigo A, Dean D . Rb interacts with histone deacetylase to repress transcription. Cell. 1998; 92(4):463-73. DOI: 10.1016/s0092-8674(00)80940-x. View

Sala A, De Luca A, Giordano A, Peschle C . The retinoblastoma family member p107 binds to B-MYB and suppresses its autoregulatory activity. J Biol Chem. 1996; 271(46):28738-40. DOI: 10.1074/jbc.271.46.28738. View

Goodrich D, Wang N, Qian Y, Lee E, Lee W . The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell. 1991; 67(2):293-302. DOI: 10.1016/0092-8674(91)90181-w. View

Dekker M, van der Valk M, Carrozza M, Jeanny J, Dannenberg J, Berns A . p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev. 1998; 12(11):1599-609. PMC: 316874. DOI: 10.1101/gad.12.11.1599. View

Dyson N . The regulation of E2F by pRB-family proteins. Genes Dev. 1998; 12(15):2245-62. DOI: 10.1101/gad.12.15.2245. View

Sterner J, Musahl C, Kornbluth S, Horowitz J . Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7. Mol Cell Biol. 1998; 18(5):2748-57. PMC: 110654. DOI: 10.1128/MCB.18.5.2748. View

Bremner R, Cohen B, Sopta M, Hamel P, Ingles C, Gallie B . Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol Cell Biol. 1995; 15(6):3256-65. PMC: 230558. DOI: 10.1128/MCB.15.6.3256. View

Ray R, Zimmerman B, McCormack S, Patel T, Johnson L . Polyamine depletion arrests cell cycle and induces inhibitors p21(Waf1/Cip1), p27(Kip1), and p53 in IEC-6 cells. Am J Physiol. 1999; 276(3):C684-91. DOI: 10.1152/ajpcell.1999.276.3.C684. View

10.

Morgan D . Determination of polyamines as their benzoylated derivatives by HPLC. Methods Mol Biol. 1998; 79:111-8. DOI: 10.1385/0-89603-448-8:111. View

11.

Hoshikawa Y, Mori A, AMIMOTO K, Iwabe K, Hatakeyama M . Control of retinoblastoma protein-independent hematopoietic cell cycle by the pRB-related p130. Proc Natl Acad Sci U S A. 1998; 95(15):8574-9. PMC: 21117. DOI: 10.1073/pnas.95.15.8574. View

12.

Luk G, Yang P . Polyamines in intestinal and pancreatic adaptation. Gut. 1987; 28 Suppl:95-101. PMC: 1434546. DOI: 10.1136/gut.28.suppl.95. View

13.

Jiang H, Karnezis A, Tao M, GUIDA P, Zhu L . pRB and p107 have distinct effects when expressed in pRB-deficient tumor cells at physiologically relevant levels. Oncogene. 2000; 19(34):3878-87. DOI: 10.1038/sj.onc.1203722. View

14.

Auvinen M, Paasinen A, Andersson L, Holtta E . Ornithine decarboxylase activity is critical for cell transformation. Nature. 1992; 360(6402):355-8. DOI: 10.1038/360355a0. View

15.

Kondo T, Higashi H, Nishizawa H, Ishikawa S, ASHIZAWA S, Yamada M . Involvement of pRB-related p107 protein in the inhibition of S phase progression in response to genotoxic stress. J Biol Chem. 2001; 276(20):17559-67. DOI: 10.1074/jbc.M009911200. View

16.

Gu W, Bhatia K, Magrath I, Dang C, Dalla-Favera R . Binding and suppression of the Myc transcriptional activation domain by p107. Science. 1994; 264(5156):251-4. DOI: 10.1126/science.8146655. View

17.

Dignam J, Lebovitz R, Roeder R . Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983; 11(5):1475-89. PMC: 325809. DOI: 10.1093/nar/11.5.1475. View

18.

Pegg A, Shantz L, Coleman C . Ornithine decarboxylase as a target for chemoprevention. J Cell Biochem Suppl. 1995; 22:132-8. DOI: 10.1002/jcb.240590817. View

19.

McCann P, Pegg A . Ornithine decarboxylase as an enzyme target for therapy. Pharmacol Ther. 1992; 54(2):195-215. DOI: 10.1016/0163-7258(92)90032-u. View

20.

Ferreira R, Robin P, Harel-Bellan A, Trouche D . The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc Natl Acad Sci U S A. 1998; 95(18):10493-8. PMC: 27922. DOI: 10.1073/pnas.95.18.10493. View